At the 2026 ASCRS Annual Meeting in Washington, DC, several presentations converged on a set of questions that define the ...

Patients who received the Tecnis PureSee extended depth of focus IOL had a high tolerance to residual refractive error, ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and ...

Opus Genetics and Viatris (through its affiliate) are parties to a global licensing agreement which provides for the development of phentolamine ophthalmic solution 0.75% and grants exclusive rights ...